You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials

Article metrics

Article menu

Download PDFPDF

XML
Evidence based practice
Research
Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials

 

Online download statistics by month:

Online download statistics by month: January 2019 to November 2023

AbstractFullPdf
Jan 201915391533357
Feb 201911181076292
Mar 2019529498126
Apr 2019642616129
May 2019695683102
Jun 2019678641114
Jul 2019610605119
Aug 201962362287
Oct 2019742742119
Nov 2019764763112
Dec 201969569579
Jan 2020797795100
Feb 2020824824103
Mar 2020722721110
May 2020485485175
Jun 2020455448176
Jul 2020458440184
Aug 2020472454111
Sep 2020599569247
Oct 2020729711179
Nov 2020679666151
Dec 2020587569146
Jan 2021608585140
Feb 2021552537146
Mar 2021635615151
Apr 2021646638157
May 2021631629189
Jun 2021560550150
Jul 2021703700159
Aug 2021773767159
Sep 2021760754156
Oct 2021706688158
Nov 2021388364132
Dec 2021568564133
Jan 2022721727158
Feb 2022570561143
Mar 2022679669215
Apr 2022680647167
May 2022658622184
Jun 202258557097
Jul 2022541517129
Aug 2022696671130
Sep 2022532517149
Oct 2022591562150
Nov 2022468451144
Dec 2022432416149
Jan 2023443433103
Feb 2023906784107
Mar 20231021984170
Apr 2023558504160
May 2023439428178
Jun 2023385372104
Jul 2023438414130
Aug 2023544490127
Sep 2023382339148
Oct 2023412375134
Nov 2023498440216
Total36151350408540